Comparative efficacy of <i>Helicobacter pylori</i> eradication therapy between tegoprazan‐based concomitant and bismuth quadruple therapies: A real‐world evidence
The eradication rates of tegoprazan-based 10-day concomitant therapy and 14-day bismuth quadruple therapy were comparable. However, because of its shorter treatment duration, better medical adherence, and lower incidence of adverse events, tegoprazan-based concomitant therapy may be preferable in regions with high rates of clarithromycin and metronidazole resistance.
Authors
- Yoon Suk Jung (ORCID: https://orcid.org/0000-0002-1963-7170)
- Byung Wook Jung (ORCID: https://orcid.org/0000-0002-8942-4031)
- Chan Hyuk Park (ORCID: https://orcid.org/0000-0003-3824-3481)
Institutions
- Yonsei University (KR)
- Kangbuk Samsung Hospital (KR)
- Hanyang University Guri Hospital (KR)
- Primary HealthCare (MT)
- Chung-Ang University Hospital (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2024-11-18
- DOI
- https://doi.org/10.1111/jgh.16798
- Citations
- 2
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 1.15